Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1.1 Primary Research Methodology
3.1.2 Secondary Research Methodology
3.1.3 Market Share Analysis
3.1.4 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Improvement in surgical outcomes (Impact weightage - 35% )
4.2.2 Increasing Prevalence of Chronic Diseases (Impact weightage - 25%)
4.2.3 Acceptance of Advanced Medical Implants Devices by Patients (Impact weightage - 25% )
4.2.4 Increasing Ageing World Population (Impact weightage - 15% )
4.3 Restraints
4.3.1 High cost of the devices (Impact weightage - 60%)
4.3.2 Ambiguous Regulatory Framework (Impact weightage - 40%)
4.4 Opportunity
4.5 Mega Trends
4.6 Macroeconomic indicators
5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Price Analysis
5.3 Supply Chain Analysis
5.4 Value Chain Analysis
5.4.1 Supporting Activity
5.4.2 Inbound Logistics
5.4.3 Operations
5.4.4 Marketing and sales
5.4.5 Outbound Logistics
5.4.6 Customer Services
5.5 Investment Opportunity Analysis
6 Global Medical Implants Market, by Type
6.1 Introduction
6.2 Orthopedic Implants
6.3 Cardiac Implants
6.4 Spinal Implants
6.5 Dental Implants
6.6 Ophthalmic Implants
6.7 Cosmetic Implants
6.8 Others
7 Global Medical Implants Market, by Type of Material
7.1 Introduction
7.2 Metallic Material
7.3 Ceramic Material
7.4 Polymers Material
7.5 Others
8 Global Medical Implants Market, by End User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Research Laboratories
8.4 Others
9 Global Medical Implants Market By Region
9.1 Americas
9.1.1 North America
9.1.1.1 U.S.
9.1.1.2 Canada
9.1.2 South America
9.2 Europe
9.2.1 Western Europe
9.2.1.1 Germany
9.2.1.2 France
9.2.1.3 U.K
9.2.1.4 Italy
9.2.1.5 Spain
9.2.1.6 Rest of Western Europe
9.2.2 Eastern Europe
9.3 Asia-pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 Republic of Korea
9.3.6 Rest of Asia-Pacific
9.4 The Middle East & Africa
9.4.1 Middle east
9.4.2 Africa
10 Competitive Landscape
10.1 Introduction
10.2 Company Share Analysis
10.3 Recent Development
11 Company Profile
11.1 Boston Scientific Corporation
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Products
11.1.4 Strategy
11.1.5 Key Developments
11.2 Medtronic
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Products
11.2.4 Strategy
11.2.5 Key Developments
11.3 Johnson & Johnson Services, Inc
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Products
11.3.4 Strategy
11.3.5 Key Developments
11.4 3M
11.4.1 Company Overview
11.4.2 Financials
11.4.3 Products
11.4.4 Strategy
11.4.5 Key Developments
11.5 Institut Straumann AG
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Products
11.5.4 Strategy
11.5.5 Key Developments
11.6 Stryker Corporation
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Products
11.6.4 Strategy
11.6.5 Key Developments
11.7 Zimmer Biomet Holdings, Inc.
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Products
11.7.4 Strategy
11.7.5 Key Developments
11.8 Smith & Nephew
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Products
11.8.4 Strategy
11.8.5 Key Developments
11.9 Dentsply Sirona
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Products
11.9.4 Strategy
11.9.5 Key Developments
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO's View Point
12.1.2 Unmet Needs
12.2 Key companies to watch
13 Appendix
13.1 Discussion Blue Print